The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials.
We used hypothetical entry criteria typical of those used in clinical therapeutic trials to determine the patients who would have been eligible among those followed in a clinic-based study of multiple sclerosis (MS) in London, Ontario, between 1972 and 1984. For these patients, we determined the obs...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Jezik: | English |
| Izdano: |
1991
|
| _version_ | 1826302077940269056 |
|---|---|
| author | Weinshenker, BG Rice, G Noseworthy, J Carriere, W Baskerville, J Ebers, G |
| author_facet | Weinshenker, BG Rice, G Noseworthy, J Carriere, W Baskerville, J Ebers, G |
| author_sort | Weinshenker, BG |
| collection | OXFORD |
| description | We used hypothetical entry criteria typical of those used in clinical therapeutic trials to determine the patients who would have been eligible among those followed in a clinic-based study of multiple sclerosis (MS) in London, Ontario, between 1972 and 1984. For these patients, we determined the observed frequency of deterioration by 1 point on the disability status scale (DSS) of Kurtzke, which is the most feasible and frequently used endpoint in clinical trials. We calculated the number of patients required for a randomized clinical trial to detect a significant result (alpha = 0.05) with 80% or 90% power based on the observed rate of deterioration. To assess the linearity of the DSS, we determined the frequency of progression and staying time at each level of the DSS. Overall the frequency of progression was lower and the staying times were longer at higher levels of disability. There was considerable intrapatient as well as interpatient variation in staying time. These data have major implications for the design and conduct of clinical therapeutic trials in MS. |
| first_indexed | 2024-03-07T05:42:03Z |
| format | Journal article |
| id | oxford-uuid:e5e84a15-0fdb-4767-a8bb-97480e407fb5 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:42:03Z |
| publishDate | 1991 |
| record_format | dspace |
| spelling | oxford-uuid:e5e84a15-0fdb-4767-a8bb-97480e407fb52022-03-27T10:27:23ZThe natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e5e84a15-0fdb-4767-a8bb-97480e407fb5EnglishSymplectic Elements at Oxford1991Weinshenker, BGRice, GNoseworthy, JCarriere, WBaskerville, JEbers, GWe used hypothetical entry criteria typical of those used in clinical therapeutic trials to determine the patients who would have been eligible among those followed in a clinic-based study of multiple sclerosis (MS) in London, Ontario, between 1972 and 1984. For these patients, we determined the observed frequency of deterioration by 1 point on the disability status scale (DSS) of Kurtzke, which is the most feasible and frequently used endpoint in clinical trials. We calculated the number of patients required for a randomized clinical trial to detect a significant result (alpha = 0.05) with 80% or 90% power based on the observed rate of deterioration. To assess the linearity of the DSS, we determined the frequency of progression and staying time at each level of the DSS. Overall the frequency of progression was lower and the staying times were longer at higher levels of disability. There was considerable intrapatient as well as interpatient variation in staying time. These data have major implications for the design and conduct of clinical therapeutic trials in MS. |
| spellingShingle | Weinshenker, BG Rice, G Noseworthy, J Carriere, W Baskerville, J Ebers, G The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. |
| title | The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. |
| title_full | The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. |
| title_fullStr | The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. |
| title_full_unstemmed | The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. |
| title_short | The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. |
| title_sort | natural history of multiple sclerosis a geographically based study 4 applications to planning and interpretation of clinical therapeutic trials |
| work_keys_str_mv | AT weinshenkerbg thenaturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT riceg thenaturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT noseworthyj thenaturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT carrierew thenaturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT baskervillej thenaturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT ebersg thenaturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT weinshenkerbg naturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT riceg naturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT noseworthyj naturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT carrierew naturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT baskervillej naturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials AT ebersg naturalhistoryofmultiplesclerosisageographicallybasedstudy4applicationstoplanningandinterpretationofclinicaltherapeutictrials |